Form 4: Itron CEO Thomas Deitrich Exercises and Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Itron's CEO, Thomas Deitrich, executed stock options and sold shares of common stock on January 3, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- On January 3, 2025, Thomas Deitrich, the President and CEO of Itron, Inc., exercised stock options to acquire 34,787 shares of Itron common stock at a price of $35.13 per share.
- Simultaneously, Deitrich sold 34,787 shares of Itron common stock at a weighted average price of $110.198 per share, with individual sales ranging from $110.000 to $110.610.
- These transactions were conducted under a Rule 10b5-1 trading plan adopted on May 6, 2024.
- Following these transactions, Deitrich directly owns 204,393 shares of Itron common stock and indirectly owns 25,000 shares through a trust.
Sentiment
Score: 6
Explanation: Neutral sentiment as the document reports routine transactions under a pre-arranged trading plan. No indication of positive or negative implications for the company's performance.
Positives
- The transactions were conducted under a pre-arranged 10b5-1 trading plan, which can mitigate concerns about insider trading.
Risks
- Executive stock sales can sometimes be perceived negatively by investors, although the use of a 10b5-1 plan helps to alleviate these concerns.
Future Outlook
The document does not contain any specific forward-looking statements or guidance.
Industry Context
Executive stock transactions are common and are often scrutinized by investors. The use of a 10b5-1 trading plan is a standard practice to ensure compliance with insider trading regulations.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units as incentives.
- The exercise and sale of shares by executives are typical occurrences, especially when part of a pre-planned trading strategy.
- Companies like Siemens, Landis+Gyr, and Badger Meter, which operate in similar sectors, also have executives who periodically exercise options and sell shares.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the use of a 10b5-1 plan mitigates concerns about insider information.
Key Dates
| Date | Description |
|---|---|
| 2018-12-10 | Stock option became fully vested. |
| 2024-05-06 | Date of adoption of Rule 10b5-1 Trading Plan by Mr. Deitrich. |
| 2025-01-03 | Date of stock option exercise and share sale. |
| 2025-01-06 | Date of signature of the Form 4 filing. |
| 2025-12-10 | Expiration date of the stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.